NGVT to Evaluate Strategic Alternatives for Industrial Specialties

Core Viewpoint - Ingevity Corporation (NGVT) is exploring strategic alternatives for its Performance Chemicals Industrial Specialties product line, which may include divesting part of its North Charleston site, while excluding certain product lines [1][3]. Group 1: Strategic Review and Financial Performance - The strategic review aims to enhance shareholder value by allowing the company to concentrate on higher growth and margin opportunities, thereby improving earnings and cash flow [2]. - Ingevity anticipates reporting net sales of approximately $1.4 billion and an adjusted EBITDA of around$360 million for fiscal 2024, with free cash flow expected to exceed $40 million [4]. - The company has gained positive momentum, with expectations to deliver adjusted EBITDA modestly above$400 million in fiscal 2025, excluding impacts from the strategic review [5]. Group 2: Market Performance - NGVT's shares have increased by 8.6% over the past year, contrasting with a 17.1% decline in its industry [6].